Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Placenta. 2015 Jun 15;36(8):903–910. doi: 10.1016/j.placenta.2015.06.002

Figure 3.

Figure 3

Placental fatty acid transporter mRNA expression in control (CTR), high fat fed (HFD) and resveratrol supplemented (HFD RES) non-human primates. FABPpm (A) and FATP4 (B) mRNA expression was decreased in placentas of HFD animals, but resveratrol supplementation normalized these levels, and in the case of FABPpm, upregulated them above control. CD36 mRNA expression was increased with resveratrol supplementation (C). Diet sensitivity was not associated with detectable differences in placental fatty acid transporter expression (data not shown). Data are mean ± SEM *P<0.05 vs CTR; **P<0.05 vs CTR, HFD by ANOVA and Tukey’s posthoc test.